AB041. PS02.05: Predictive value of 18FDG-PET/CT on preoperative management of thymic tumours
Poster Session 2

AB041. PS02.05: Predictive value of 18FDG-PET/CT on preoperative management of thymic tumours

Valentina Tassi1, Silvia Ceccarelli1, Rosanna Capozzi1, Valeria Liparulo1, Niccolò Daddi2, Alessio Gili3, Salvatore Messina4, Silvio Sivolella5, Francesco Puma1

1Thoracic Surgery Unit, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy;2Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, University of Bologna, Bologna, Italy;3Department of Experimental Medicine, University of Perugia, Perugia, Italy;4Nuclear Medicine Section, S. Maria Della Misericordia Hospital, Perugia, Italy;5Nuclear Medicine Section, San Giovanni Battista Hospital, Foligno, Italy


Background: Exiguous data exist on the usefulness of FDG-PET/CT in the pre-operative staging process of thymic epithelial tumours. Aim of this study is to investigate the role of nuclear imaging on predicting their malignancy and invasiveness.

Methods: Retrospective, single-centre analysis of 49 patients operated from January 2010 to December 2016. The FDG-PET/CT parameters evaluated for our analysis were: tumour SUVmax (T); tumour SUVmax/tumour size (T/d); tumour SUVmax/volume (T/vol); tumour to spleen (T/S), tumour to liver (T/L), tumour to blood pool (T/BP) SUVmax ratio. WHO-histological types were grouped in: low-risk (A, AB, B1) vs. high-risk (B2, B3, carcinoma) tumours or thymomas vs. carcinomas. Masaoka stage were considered as low (I, II) and high (III, IV). Student’s t-test for paired data, Spearman’s rank correlation index and ROC curve after logistic regression were performed.

Results: There were 27 males and 22 females, mean age 61 years (range, 29–83). WHO histology: 5 (10.20%) A, 16 (32.65%) AB, 4 (8.16%) B1, 12 (24.45%) B2, 4 (8.16%) B3, 8 (16.33%) carcinomas. Masaoka stage: 25 (51.02%) I, 10 (20.41%) II, 6 (12.24%) III, 8 (16.33%) IV. There were no statistically significant differences in tumour size and volume neither between low-risk and high-risk tumours nor between thymomas and carcinomas. T (r: 0.59; P<0.0001), T/d (r: 0.49; P=0.0003), T/S (r: 0.50; P=0.0009), T/L (r: 0.48; P=0.001), T/BP (r: 0.45; P=0.003) significantly correlated with histology. Similarly, T (r: 0.5; P=0.0002), T/d (r: 0.3; P=0.02), T/S (r: 0.3; P=0.02), T/L (r: 0.3; P=0.02), T/BP (r: 0.3; P=0.01) significantly correlated with stage. No correlation was observed between T/vol and histology nor stage. According to univariate logistic regression model, T and T/d resulted as predictive factors in distinguishing low-risk from high-risk tumours (P=0.02, area under ROC-curve: 0.763 and P=0.008, area under ROC-curve: 0.767, respectively). All the parameters but T/vol were predictive to define thymic carcinomas from thymomas; in particular, the most effective was T (P=0.001, area under ROC-curve: 0.939). T, T/S, T/L, T/BP were all found to be useful to distinguish low from high stages, but T and T/L resulted as the most significant (P=0.01, area under ROC-curve: 0.784 and P=0.02, area under ROC-curve: 0.736, respectively).

Conclusions: FDG-PET/CT may be helpful to assess the grade of malignancy and to distinguish low from high stages.

Keywords: FDG-PET/CT; thymic epithelial tumours; SUVmax


doi: 10.21037/med.2017.AB041


Cite this article as: Tassi V, Ceccarelli S, Capozzi R, Liparulo V, Daddi N, Gili A, Messina S, Sivolella S, Puma F. Predictive value of 18FDG-PET/CT on preoperative management of thymic tumours. Mediastinum 2017;1:AB041. doi: 10.21037/med.2017.AB041

Download Citation